The plant protein industry spent a decade masking a problem it could have solved

Pea protein's taste problem was supposedly solved years ago. So why is a Zurich startup getting credit for it now?

If removing off-flavors from plant proteins is this straightforward, why hasn't anyone done it before — and what does that reveal about an industry that built its business on masking problems instead of solving them?

That is the uncomfortable question SentiaNova, a Geneva-backed startup that emerged from stealth last week, is asking its competitors to answer. The company has developed a patented process it claims eliminates off-flavors from pulse proteins — peas, chickpeas, fava beans — at source, rather than masking them with flavor systems downstream. Samples are available now; commercial sales are targeted for the fourth quarter of 2026.

The technology is real. The scientific basis is not in dispute. Off-flavors in pulse proteins — the earthy, vegetal notes that limit their use in high-protein applications — can be reduced or removed through enzymatic treatment, fermentation, solvent extraction, or variations of all three, according to peer-reviewed literature MDPI Foods dating back years. What is new is a company backed by a small amount of venture funding, with a named CEO, coming to market with a product that incumbents say they already sell.

The incumbents moved first

Roquette, the French ingredient giant, launched NUTRALYS Pea 850F in February this year — a pea protein isolate specifically formulated, in its own words, "to unlock superior sensory performance" with "significantly reducing vegetal or pea notes" Roquette. Ingredion, the US-based ingredient company, has been selling its Prista line of deflavored pulse ingredients since 2021 and expanded the range in February 2026 Ingredion.

Both are billion-dollar companies with established customer relationships, industrial-scale manufacturing, and products that have already passed through the formulation pipelines of major food brands. Ingredion's Prista line was explicitly developed to solve the same problem SentiaNova is describing. Roquette's product was developed with sensory panel testing confirming reduced vegetal notes.

"Pea protein provides excellent nutrition and functionality in plant-based and high protein foods and beverages, but sensory performance has remained a critical barrier to wider adoption," Benjamin Voiry, global protein product marketing at Roquette, said in the company's launch statement Roquette. "Consumers understandably want the protein hit without the overpowering vegetal taste."

The gap between what incumbents say they offer and what SentiaNova is claiming to offer has not been clearly established in the public record. SentiaNova has not published sensory panel data. It has not named a customer. It has not disclosed the specific mechanism of its patented process, beyond describing it as addressing off-flavors "at source."

Why did it take this long?

The more interesting question — and the one that separates this story from a product announcement — is structural.

The food ingredients industry has known about pulse protein off-flavors for decades. Burcon Nutrascience, a Canadian company, filed a patent on pulse protein processing methods in 2015 (granted in 2017) that described approaches to addressing flavor issues in pea and other pulse proteins EPO. Researchers at multiple universities have published on enzymatic treatment, fermentation, and supercritical CO2 extraction as approaches to off-flavor reduction. The scientific literature is not sparse.

What the industry built instead was a masking infrastructure. Flavor houses developed proprietary systems specifically designed to cover pea and soy notes. Blending specialists created protein combinations where the off-notes of one protein were drowned out by others. Product developers learned to work around the limitation — adding masking agents, adjusting pH, using flavor systems as crutches.

The masking industry was profitable. The root-cause solution apparently was not prioritized.

"Large food companies have cut back or reshaped early experiments," Giacomo Cattaneo, co-founder of FOOD FOUNDERS Studio — the Zurich venture studio that built SentiaNova — said in an interview with Better Bioeconomy Better Bioeconomy. "Some have closed in-house brand pilots, others have turned incubators into corporate VC groups, and most have raised the bar for trials."

This is consistent with broader patterns in food tech investment. The Good Food Institute's analysis of 2025 investment data shows total alternative protein funding fell to $881 million from $1.1 billion in 2024 — a decline of roughly 20 percent. But the split within that number is revealing: plant-based protein funding rose 39 percent to $450 million, while fermentation dropped 43 percent and cultivated meat fell 48 percent FoodNavigator.

The money that stayed in plant-based went toward the unglamorous work of ingredient improvement and cost reduction — exactly the kind of infrastructure-layer problem that FOOD FOUNDERS is targeting with SentiaNova.

What SentiaNova actually is

FOOD FOUNDERS Studio raised CHF 1.2 million ($1.36 million) in seed funding in September 2025 and launched SentiaNova as its first company Startupticker. The studio's model — identifying an industry pain point first, then finding academic science to solve it, then recruiting a commercial founder to run the resulting company — is designed specifically to bridge the gap between lab and market that has historically trapped food tech innovations Better Bioeconomy.

CEO Daria Reisch previously co-founded Agrinorm, a technology company focused on fresh produce sourcing. She is not a food scientist. The studio model assumes the commercial operator is the scarce resource, not the underlying science.

This is a coherent theory of the case. Whether it produces a defensible competitive advantage in an ingredient market where Ingredion and Roquette are already selling competing products is the central commercial question the company will need to answer before the fourth quarter.

SentiaNova's tasting event page describes the product outcome in absolute terms: "a protein so neutral, food scientists don't know what they're tasting" Luma. That is a compelling claim. It is also a claim that Roquette is essentially making for NUTRALYS 850F, and Ingredion has been making for Prista since 2021.

The real test — blind comparative sensory data from an independent panel — has not been published by anyone in this space.

The story worth telling

The SentiaNova launch, in isolation, is not a story. A startup with a patented process, a pre-seed funding round, no named customers, and a targeted commercial timeline faces the same gauntlet every ingredient startup faces: proving that what works in the lab scales to industrial volumes at a price that makes formulators switch from established alternatives.

What makes this worth covering is the structural question it surfaces.

The plant protein industry spent a decade building around a known technical problem rather than solving it. The companies that developed masking solutions captured value from that problem's existence. The companies that might have solved it at source — academic labs, ingredient specialists — did not have the commercial infrastructure or the incentive structure to push solutions into market.

Now a venture studio has built a company specifically to do that pushing, and the incumbents are already in the market with what they describe as solutions.

The result is a competitive situation that is genuinely difficult to evaluate from the outside: are incumbents underselling their own deflavoring capabilities? Is SentiaNova's approach materially different? Or is this a case where the labeling of a problem as "solved" by incumbents is itself what prevented the market from understanding how far the problem had actually been solved?

That is the story. The answer — which would require access to proprietary sensory data and formulation economics that no company in this space has an incentive to publish — may not be available for quarters.

What is clear is that the industry knew this problem existed, knew it constrained the market for plant protein, and built a workaround economy rather than a solution economy. SentiaNova is a bet that the solution economy is finally viable. Whether it is arriving too late to matter is the question that matters most.

---

SentiaNova did not respond to a request for comment by publication time. This article will be updated if the company provides sensory data, customer names, or additional technical detail.